

Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding. The investors were Versant Ventures and New Enterprise Associates.
Source: Press Release
Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding.
Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding. The investors were Versant Ventures and New Enterprise Associates.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination